Delivery Order SPE2DB24D3015-SPE2DB24FFXCT
Award Date
8/1/24
Potential Completion Date
8/2/24
Potential Value
$5.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens with a completion date of March 6, 2024 and a potential value of $5,108.39. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations noted. This delivery order is issued under...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $33,061.50, is for the supply of Ozempic 0.25-0.5 mg/dose pens. The ultimate completion date is September 26, 2024.
AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) to provide a wide range of medical commodities, including...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $13,495.17 firm fixed-price contract is for the supply of Ozempic 0.25-0.5 mg/dose pens. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of pharmaceutical and medical supplies to support military...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract worth $1,952.72 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pen 3ml pharmaceutical products. This contract has an ultimate completion date of August 21, 2024 and is not set aside for any specific business category. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a $35,223.56 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen in 3 mL. It has an ultimate completion date of July 12, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $21,842.08, is for the supply of Ozempic 0.25-0.5 mg/dose pen 3 mL medication. The contract has an ultimate completion date of July 22, 2024 and uses a Firm Fixed Price pricing type. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its broader Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $23,267.51 firm-fixed-price contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens, with an ultimate completion date of August 14, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and DLA Troop Support Medical for...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Ozempic 0.25-0.5 mg/dose pens with a 3 ml capacity. The $3,972.56 contract has a completion date of January 18, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that has received numerous awards from DLA Troop Support Medical to provide pharmaceuticals, medical supplies,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,749.20 contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat diabetes. The order has an ultimate completion date of December 3, 2024. Amerisourcebergen, a for-profit organization, is registered in the System for Award Management (SAM.gov) and has a significant Indefinite Delivery Contract (IDC) with...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award, valued at $12,416.54, is for the provision of Ozempic 0.25-0.5 mg/dose pen 3 ml, a specialty pharmaceutical product. The contract has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and is not operating under a set-aside designation.
This delivery...